These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32908905)

  • 1. Comprehensive Characterization of Prognostic Long Noncoding RNAs in Osteosarcoma.
    Gao H; Guo Y; Zhang M; Yi Z
    Biomed Res Int; 2020; 2020():6725753. PubMed ID: 32908905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis reveals driver long non-coding RNAs in osteosarcoma.
    Luo Z; Xiao L; Li J; Dong B; Wang C
    Medicine (Baltimore); 2019 Feb; 98(6):e14302. PubMed ID: 30732148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
    Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
    Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
    Ying T; Dong JL; Yuan C; Li P; Guo Q
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
    Zhang P; Xu K; Wang J; Zhang J; Quan H
    BMC Cancer; 2021 Dec; 21(1):1285. PubMed ID: 34852770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
    Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
    Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00324 accelerates the proliferation and migration of osteosarcoma through regulating WDR66.
    Wu S; Gu Z; Wu Y; Wu W; Mao B; Zhao S
    J Cell Physiol; 2020 Jan; 235(1):339-348. PubMed ID: 31225659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNAs in osteosarcoma.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    Oncotarget; 2017 Mar; 8(12):20462-20475. PubMed ID: 28103585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
    Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO
    PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of the long non‑coding RNA FOXD2‑AS1 inhibits cell proliferation, migration and invasion in osteosarcoma.
    Zhang H; Lu Y; Wang J; Zhang T; Dong C; Li X; Wang X; Ma Q; Yang T; Zhou Y
    Mol Med Rep; 2019 Jul; 20(1):292-302. PubMed ID: 31115575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
    PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma.
    Chen J; Wu Z; Zhang Y
    Int J Immunopathol Pharmacol; 2019; 33():2058738418820743. PubMed ID: 30791797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.